ZA933178B - Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration - Google Patents

Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration

Info

Publication number: ZA933178B
Authority: ZA; South Africa
Prior art keywords: pct; rectal administration; pharmaceutical compositions; receptor agonists; sec
Prior art date: 1992-05-07

Application number

ZA933178A

Other languages

English (en)

Inventor

Nadine Merlet

Isabelle Richard

Isabelle Thielemans

Original Assignee

Glaxo Lab Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-07

Filing date

1993-05-06

Publication date

1994-01-10

1993-05-06 Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa

1994-01-10 Publication of ZA933178B publication Critical patent/ZA933178B/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000000018 receptor agonist Substances 0.000 title abstract 2
229940044601 receptor agonist Drugs 0.000 title abstract 2
241000124008 Mammalia Species 0.000 abstract 1
239000002585 base Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000012458 free base Substances 0.000 abstract 1
229940116364 hard fat Drugs 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
239000007909 solid dosage form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Compositions Of Macromolecular Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

ZA933178A 1992-05-07 1993-05-06 Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration ZA933178B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB929209882A GB9209882D0 (en)	1992-05-07	1992-05-07	Compositions

Publications (1)

Publication Number	Publication Date
ZA933178B true ZA933178B (en)	1994-01-10

Family

ID=10715158

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA933178A ZA933178B (en)	1992-05-07	1993-05-06	Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration

Country Status (33)

Country	Link
US (1)	US5705506A (de)
EP (1)	EP0639072B1 (de)
JP (1)	JPH07506570A (de)
KR (1)	KR100253111B1 (de)
AT (1)	ATE163850T1 (de)
AU (1)	AU670083B2 (de)
BE (1)	BE1007024A5 (de)
BG (1)	BG62120B1 (de)
BR (1)	BR1100108A (de)
CA (1)	CA2135179C (de)
CH (1)	CH685920A5 (de)
CY (1)	CY2039B1 (de)
CZ (1)	CZ283512B6 (de)
DE (1)	DE69317418T2 (de)
ES (1)	ES2113533T3 (de)
FR (1)	FR2690847B1 (de)
GB (2)	GB9209882D0 (de)
GR (1)	GR3026584T3 (de)
HK (1)	HK95697A (de)
HU (2)	HU227338B1 (de)
IE (1)	IE75203B1 (de)
IL (1)	IL105468A (de)
IT (1)	IT1261471B (de)
NO (1)	NO306700B1 (de)
NZ (1)	NZ252132A (de)
OA (1)	OA10109A (de)
RO (1)	RO112993B1 (de)
RU (1)	RU2118527C1 (de)
SG (1)	SG46649A1 (de)
TW (1)	TW231970B (de)
UA (1)	UA37206C2 (de)
WO (1)	WO1993021916A1 (de)
ZA (1)	ZA933178B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997044062A1 (en) *	1996-05-23	1997-11-27	Alcon Laboratories, Inc.	The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en)	1997-11-06	2007-03-13	Cady Roger K	Preemptive prophylaxis of migraine
AU749623B2 (en) *	1998-03-26	2002-06-27	Astellas Pharma Inc.	Sustained release preparations
AU3731400A (en) *	1999-03-05	2000-09-21	Trustees Of University Technology Corporation, The	Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) *	2005-10-14	2007-10-17	Athersys Inc	Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
US8653066B2 (en)	2006-10-09	2014-02-18	Charleston Laboratories, Inc.	Pharmaceutical compositions
EP2240022B1 (de)	2008-01-09	2016-12-28	Charleston Laboratories, Inc.	Oxycodone und Promethazine enthaltende zweischichtige Tabletten
EP2451274B1 (de)	2009-07-08	2017-10-04	Charleston Laboratories, Inc.	Pharmazeutische zusammensetzungen
CN103402514B (zh)	2010-10-15	2016-01-13	康特拉医药公司	用于治疗运动障碍的血清素受体激动剂组合物
MY169068A (en)	2012-04-18	2019-02-12	Contera Pharma Aps	Orally available pharmaceutical formulation suitable for improved management of movement disorders
US10179109B2 (en)	2016-03-04	2019-01-15	Charleston Laboratories, Inc.	Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
CN109689036B (zh)	2016-07-11	2026-06-19	康特拉医药股份有限公司	用于治疗早晨运动不能的脉冲药物输送系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZW19381A1 (en) *	1980-08-12	1983-03-09	Glaxo Group Ltd	Heterocyclic compounds
DK157995C (da) *	1980-08-12	1990-08-06	Glaxo Group Ltd	Analogifremgangsmaade til fremstilling af indolderivater
GB2082175B (en) *	1980-08-12	1984-05-02	Glaxo Group Ltd	Heterocyclic compounds
GR79215B (de) *	1982-06-07	1984-10-22	Glaxo Group Ltd
GB8332435D0 (en) *	1983-12-06	1984-01-11	Glaxo Group Ltd	Chemical compounds
GB2162522B (en) *	1984-08-01	1988-02-24	Glaxo Group Ltd	An indole derivative
GB8419575D0 (en) *	1984-08-01	1984-09-05	Glaxo Group Ltd	Chemical compounds
US4785016A (en) *	1984-12-04	1988-11-15	Glaxo Group Limited	Indole derivatives
GB8431426D0 (en) *	1984-12-13	1985-01-23	Glaxo Group Ltd	Chemical compounds
EP0225726B1 (de) *	1985-11-08	1991-04-17	Glaxo Group Limited	Indolderivate
PH24976A (en) *	1987-08-13	1990-12-26	Glaxo Group Ltd	Indole derivatives
CZ288351B6 (en) *	1990-06-07	2001-05-16	Astrazeneca Ab	Nitrogenous heterocyclic compound, process of its preparation and use as well as a medicament containing thereof

1992
- 1992-05-07 GB GB929209882A patent/GB9209882D0/en active Pending
1993
- 1993-04-20 IL IL10546893A patent/IL105468A/en not_active IP Right Cessation
- 1993-05-03 UA UA94115989A patent/UA37206C2/uk unknown
- 1993-05-03 DE DE69317418T patent/DE69317418T2/de not_active Expired - Lifetime
- 1993-05-03 JP JP5518928A patent/JPH07506570A/ja active Pending
- 1993-05-03 US US08/331,485 patent/US5705506A/en not_active Expired - Fee Related
- 1993-05-03 AU AU40640/93A patent/AU670083B2/en not_active Ceased
- 1993-05-03 AT AT93909884T patent/ATE163850T1/de active
- 1993-05-03 NZ NZ252132A patent/NZ252132A/en not_active IP Right Cessation
- 1993-05-03 RU RU94046069/14A patent/RU2118527C1/ru not_active IP Right Cessation
- 1993-05-03 CA CA002135179A patent/CA2135179C/en not_active Expired - Fee Related
- 1993-05-03 CZ CZ942723A patent/CZ283512B6/cs not_active IP Right Cessation
- 1993-05-03 ES ES93909884T patent/ES2113533T3/es not_active Expired - Lifetime
- 1993-05-03 WO PCT/EP1993/001077 patent/WO1993021916A1/en not_active Ceased
- 1993-05-03 HU HU9403188A patent/HU227338B1/hu unknown
- 1993-05-03 EP EP93909884A patent/EP0639072B1/de not_active Expired - Lifetime
- 1993-05-03 RO RO94-01790A patent/RO112993B1/ro unknown
- 1993-05-05 SG SG1996007136A patent/SG46649A1/en unknown
- 1993-05-05 GB GB9309209A patent/GB2266665B/en not_active Expired - Lifetime
- 1993-05-06 BE BE9300467A patent/BE1007024A5/fr not_active IP Right Cessation
- 1993-05-06 IE IE930339A patent/IE75203B1/en not_active IP Right Cessation
- 1993-05-06 CH CH139793A patent/CH685920A5/fr not_active IP Right Cessation
- 1993-05-06 ZA ZA933178A patent/ZA933178B/xx unknown
- 1993-05-06 FR FR9305432A patent/FR2690847B1/fr not_active Expired - Lifetime
- 1993-05-06 IT ITRM930286A patent/IT1261471B/it active IP Right Grant
- 1993-05-12 TW TW082103742A patent/TW231970B/zh active
1994
- 1994-11-04 OA OA60578A patent/OA10109A/en unknown
- 1994-11-04 NO NO944214A patent/NO306700B1/no not_active IP Right Cessation
- 1994-11-05 KR KR1019940703950A patent/KR100253111B1/ko not_active Expired - Fee Related
- 1994-11-07 BG BG99167A patent/BG62120B1/bg unknown
1995
- 1995-06-29 HU HU95P/P00531P patent/HU211638A9/hu unknown
1996
- 1996-12-24 BR BR1100108-9A patent/BR1100108A/pt active IP Right Grant
1997
- 1997-06-26 HK HK95697A patent/HK95697A/xx not_active IP Right Cessation
1998
- 1998-04-10 GR GR980400773T patent/GR3026584T3/el unknown
- 1998-04-30 CY CY9802039A patent/CY2039B1/xx unknown

Also Published As

Publication number	Publication date
HU211638A9 (en)	1995-12-28
NZ252132A (en)	1996-09-25
IL105468A (en)	1998-09-24
NO306700B1 (no)	1999-12-13
EP0639072B1 (de)	1998-03-11
GB2266665A (en)	1993-11-10
KR100253111B1 (en)	2000-07-01
ATE163850T1 (de)	1998-03-15
IE930339A1 (en)	1993-11-17
NO944214D0 (no)	1994-11-04
HK95697A (en)	1997-08-08
BE1007024A5 (fr)	1995-02-21
BG62120B1 (bg)	1999-03-31
FR2690847A1 (fr)	1993-11-12
OA10109A (en)	1996-12-18
BG99167A (bg)	1995-06-30
RO112993B1 (ro)	1998-03-30
RU2118527C1 (ru)	1998-09-10
IE75203B1 (en)	1997-08-27
AU670083B2 (en)	1996-07-04
HUT71418A (en)	1995-11-28
BR1100108A (pt)	1999-12-07
IT1261471B (it)	1996-05-23
ES2113533T3 (es)	1998-05-01
FR2690847B1 (fr)	1995-06-09
ITRM930286A0 (it)	1993-05-06
UA37206C2 (uk)	2001-05-15
JPH07506570A (ja)	1995-07-20
EP0639072A1 (de)	1995-02-22
CY2039B1 (en)	1998-04-30
GR3026584T3 (en)	1998-07-31
US5705506A (en)	1998-01-06
GB2266665B (en)	1996-05-22
AU4064093A (en)	1993-11-29
GB9309209D0 (en)	1993-06-16
DE69317418D1 (de)	1998-04-16
WO1993021916A1 (en)	1993-11-11
TW231970B (de)	1994-10-11
CA2135179A1 (en)	1993-11-11
IL105468A0 (en)	1993-08-18
SG46649A1 (en)	1998-02-20
ITRM930286A1 (it)	1994-11-06
CH685920A5 (fr)	1995-11-15
GB9209882D0 (en)	1992-06-24
CZ283512B6 (cs)	1998-04-15
NO944214L (no)	1994-11-07
CA2135179C (en)	2000-12-05
DE69317418T2 (de)	1998-07-30
HU227338B1 (en)	2011-04-28
CZ272394A3 (en)	1995-10-18

Publication	Publication Date	Title
NZ315740A (en)	1999-06-29	Oral fast-dissolving compositionsfor dopamine agonists
AP2001002129A0 (en)	2001-06-30	5HT1 receptor agonists and metoclopramide for the treatment of migrane.
ATE331726T1 (de)	2006-07-15	Adenine-derivate
MY117274A (en)	2004-06-30	Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
MX9702865A (es)	1998-05-31	Agentes estrogenicos.
DK0641328T3 (da)	2002-05-21	Broforbundne, azabicykliske derivater som substans P-antagonister
MY136249A (en)	2008-08-29	Phenylethanolamine compounds as anti-obesity agents
ES2160949T3 (es)	2001-11-16	Derivados de fenilen-sulfonamida sustituidos en meta.
KR100253111B1 (en)	2000-07-01	Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
AU1767997A (en)	1997-09-02	Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
IL114598A0 (en)	1995-11-27	Triazole compounds their preparation and pharmaceutical compositions containing them
MXPA03000548A (es)	2004-04-05	Combinacion novedosa de agonista (5-ht2) y antagonistas (5-ht6) de serotonina como formulacion farmaceutica.
IL114600A (en)	1999-11-30	Thiazole and thiadiazole compounds their preparation and pharmaceutical compositions containing them
BG104008A (en)	2000-07-31	Insulin resistance tretment with growth hormone secretagogues
GR3022615T3 (en)	1997-05-31	Pharmaceutical compositions based on ebastime or analogues thereof.
WO2000000198A8 (en)	2000-03-23	Piperidine derivatives having effects on serotonin related systems
EP1064966A3 (de)	2003-01-08	Zusammensetzungen von 5HT1-Rezeptor -Antagonisten, Koffein und COX-2 Inhibitoren zur Behandlung von Migräne
GR3036195T3 (en)	2001-10-31	Novel compounds
EP1064948A3 (de)	2003-01-08	Zusammensetzungen von 5HT1-Rezeptor -Antagonisten, Koffein und COX-2 Inhibitoren zur Behandlung von Migräne
EP1051994A3 (de)	2003-01-08	5HT1-Rezeptor-Agonisten und COX-2 Inhibitoren zur Behandlung von Migräne